Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Settles Patent Dispute with Bioscientia Institute

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled a legal dispute with Bioscientia Institute for Medical Diagnostics and will withdraw its lawsuit against the German firm.

Melbourne, Australia-based GTG initiated legal action against Bioscientia in March related to GTG's non-coding technology. The company did not disclose details about the lawsuit, but GTG has sued numerous companies, alleging infringement of US Patent No. 5,612,179.

It has settled with several firms over its allegations, and today's announcement follows similar settlements announced in April with the Genetics & IVF Institute and PreventionGenetics.

Financial and other terms of today's deal were not disclosed.